Share Your Story & Stay Connected

Patient Experience Survey

We would love to hear about your experience. Inquire about our patient experience survey and make your voice heard.

Share Your Story

Our founders Dr. Chelsea Bahney and Dr. Sarah Knox are personally motivated by the real stories and daily struggles of people struggling with xerostomia and are dedicated to making a meaningful difference.

Read Our Founding Story

Stay Informed on Recent Progress

Sign up for our mailing list and be the first to receive updates about our upcoming clinical trial.

Request Updates

Upcoming Clinical Trial (2027)

Hydronovo is advancing Ceviginate (CVGN8), a first-of-its-kind regenerative therapy designed to restore salivary gland function. Unlike current treatments that provide only temporary symptom relief, our approach aims to repair damaged gland tissue and provide long-lasting, meaningful results by addressing the root cause of xerostomia. 

We are preparing for a Phase I clinical trial in early 2027.

A Note of Hope

Living with chronic dry mouth can feel isolating and frustrating, but you deserve better. We are working tirelessly to develop a treatment that truly makes a difference. Your participation in the Hydronovo patient community means the world to us. Every voice helps us understand what matters most and guides us towards developing therapies that address real patient needs.

Together, we are building a future where xerostomia does not have to be a lifelong burden.

Thank you for being part of this journey.

The Hydronovo Team

*Your privacy is important to us. All personal information is kept strictly confidential, and we will never share identifiable details without your explicit permission. By submitting your story, you consent to Hydronovo using de-identified information for research, educational, or awareness purposes. De-identified means all personal details are removed—you remain anonymous, but your story may help others.